Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/Hannan/141965
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVrcek, Ivan-
dc.contributor.authorChoudhury, Eileen-
dc.contributor.authorDurairaj, Vikram-
dc.date.accessioned2017-04-18T11:25:46Z-
dc.date.available2017-04-18T11:25:46Z-
dc.date.issued2017-01-
dc.identifier.issn10.1016/j.amjmed.2016.08.039-
dc.identifier.urihttp://dl.umsu.ac.ir/handle/Hannan/141965-
dc.description.abstractHerpes zoster ophthalmicus occurs due to reactivation of the varicella zoster virus in the ophthalmic branch of the fifth cranial nerve. This disease primarily affects the elderly as well as the immunocompromised and can result in a wide range of ophthalmic morbidity. Systemic antiviral therapy is the mainstay of treatment; however, consultation with an ophthalmologist is typically indicated. Herein we present a review of this common entity including epidemiology, pathophysiology, evaluation, treatment, follow-up, and an update on the current body of literature.en_US
dc.language.isoenen_US
dc.titleHerpes Zoster Ophthalmicus: A Review for the Internisten_US
Appears in Collections:American Journal of Medicine 2017

Files in This Item:
File SizeFormat 
The American Journal of Medicine-J-2-Vol-130-Issu-1-Jan-2017=21.pdf815.55 kBAdobe PDFDownload


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.